Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
50
MBOT Quote, Financials, Valuation and Earnings
Last price:
$2.37
Seasonality move
:
46.39%
Day range:
$2.33 - $2.53
52-week range:
$0.93 - $4.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.03x
Volume:
3M
Avg. volume:
2.8M
1-year change:
149.05%
Market cap:
$159.2M
Revenue:
--
EPS (TTM):
-$0.45
Analysts' Opinion
-
Consensus RatingMicrobot Medical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.75, Microbot Medical, Inc. has an estimated upside of 269.2% from its current price of $2.37.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.50 representing 100% downside risk from its current price of $2.37.
Fair Value
-
According to the consensus of 2 analysts, Microbot Medical, Inc. has 269.2% upside to fair value with a price target of $8.75 per share.
MBOT vs. S&P 500
-
Over the past 5 trading days, Microbot Medical, Inc. has underperformed the S&P 500 by -2.37% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Microbot Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Microbot Medical, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Microbot Medical, Inc. reported revenues of --.
Earnings Growth
-
Microbot Medical, Inc. has grown year-over-year earnings for 12 quarters straight. In the most recent quarter Microbot Medical, Inc. reported earnings per share of -$0.07.
Enterprise value:
79.9M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-7.25x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$63K
Return On Assets:
-41.62%
Net Income Margin (TTM):
--
Return On Equity:
-45.11%
Return On Invested Capital:
-44.68%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$104K | -$100K | -$63K | -$23K | -$10K | |
| Operating Income | -$10.9M | -$10.3M | -$14M | -$3.3M | -$3.9M | |
| EBITDA | -$10.8M | -$10.2M | -$14M | -$3.3M | -$3.9M | |
| Diluted EPS | -$1.20 | -$0.80 | -$0.45 | -$0.20 | -$0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $18.8M | $6.6M | $8.4M | $5M | $80.8M | |
| Total Assets | $19.7M | $7.4M | $8.9M | $5.2M | $81.8M | |
| Current Liabilities | $1.4M | $1.7M | $1.5M | $1.4M | $2.9M | |
| Total Liabilities | $1.8M | $1.9M | $1.5M | $1.4M | $3.5M | |
| Total Equity | $17.9M | $5.5M | $7.4M | $3.8M | $78.2M | |
| Total Debt | $703K | $226K | $39K | $29K | $602K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.2M | -$9M | -$11M | -$2.8M | -$3.8M | |
| Cash From Investing | -$4.7M | $3M | -$69.4M | $140K | -$44.7M | |
| Cash From Financing | $10.9M | $5.1M | $86.6M | $633K | $51.2M | |
| Free Cash Flow | -$9.2M | -$9M | -$11M | -$2.8M | -$3.9M | |
MBOT
Sector
Market Cap
$159.2M
$28.5M
Price % of 52-Week High
50.75%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-43.19%
-1.33%
1-Year Price Total Return
149.05%
-20.32%
Beta (5-Year)
1.171
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.30
200-day SMA
Sell
Level
$2.52
Bollinger Bands (100)
Sell
Level
2.24 - 3.48
Chaikin Money Flow
Sell
Level
-15.2M
20-day SMA
Buy
Level
$2.11
Relative Strength Index (RSI14)
Buy
Level
53.85
ADX Line
Buy
Level
31.4
Williams %R
Neutral
Level
-22.093
50-day SMA
Sell
Level
$2.47
MACD (12, 26)
Buy
Level
0.08
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-900.8K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-21.5912)
Sell
CA Score
(Annual)
Level (-7.4933)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (13.5159)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
Stock Forecast FAQ
In the current month, MBOT has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MBOT average analyst price target in the past 3 months is $8.75.
-
Where Will Microbot Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Microbot Medical, Inc. share price will rise to $8.75 per share over the next 12 months.
-
What Do Analysts Say About Microbot Medical, Inc.?
Analysts are divided on their view about Microbot Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Microbot Medical, Inc. is a Sell and believe this share price will drop from its current level to $5.50.
-
What Is Microbot Medical, Inc.'s Price Target?
The price target for Microbot Medical, Inc. over the next 1-year time period is forecast to be $8.75 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MBOT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Microbot Medical, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MBOT?
You can purchase shares of Microbot Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Microbot Medical, Inc. shares.
-
What Is The Microbot Medical, Inc. Share Price Today?
Microbot Medical, Inc. was last trading at $2.37 per share. This represents the most recent stock quote for Microbot Medical, Inc.. Yesterday, Microbot Medical, Inc. closed at $2.37 per share.
-
How To Buy Microbot Medical, Inc. Stock Online?
In order to purchase Microbot Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MBOT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MBOT
Sector
P/E ratio
--
23.75x
PEG ratio
--
-0.01x
P/B ratio
2.03x
1.83x
Price / LTM sales
--
1.60x
Growth Metrics
MBOT
Sector
Revenue growth
--
4.85%
Earnings growth
61.89%
11.11%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.08
-$0.20
Profitability
MBOT
Sector
Profitability FY 2024
-$91K
$3.6M
Return on invested capital
-44.68%
-30.98%
Return on assets
-41.62%
-27.62%
Return on equity
-45.11%
-36.69%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
Dec
7
Estimated Next Earnings Date
Mar
8
Balance Sheet
MBOT
Sector
Total cash
$80.2M
$27.2M
Short term investments
$2.4M
$25.7M
Total assets
$6M
$79.7M
Long term debt
$602K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
